[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Quantumup1 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1060595604022280192.png) quantumup [@Quantumup1](/creator/twitter/Quantumup1) on x 3534 followers
Created: 2025-07-14 10:24:50 UTC

Jefferies🏁 $BBIO Buy-$70 and said, "We believe Attruby (oral TTR stabilizer) could become a $4B+ blockbuster pill in ATTR-CM heart disorder (a
pot'l $20B TAM)" - doc suggest add'l ⬆️side if Attruby real-world efficacy proves differentiated over tafamidis.
$PFE $ALNY
Citi reiterated $BBIO Buy-$67 after BridgeBio held an educational webinar to discuss pipeline drug BBP-418 and limb-girdle muscular dystrophy type 21/R9 (LGMD21/R9).

Jefferies and Citi said in their research reports:

![](https://pbs.twimg.com/media/Gvz6KxvXIAARxH3.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944704636255867377/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[$alny](/topic/$alny)
[realworld](/topic/realworld)
[$20b](/topic/$20b)
[$4b](/topic/$4b)
[$bbio](/topic/$bbio)
[$pfe](/topic/$pfe)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Quantumup1/status/1944704636255867377)